Published: 30 May 2020
Author(s): Fabio Alfredo Sgura, Salvatore Arrotti, Paolo Magnavacchi, Daniel Monopoli, Davide Gabbieri, Federico Banchelli, Stefano Tondi, Andrea Denegri, Roberto D'Amico, Vincenzo Guiducci, Luigi Vignali, Giuseppe Boriani
Section: Original article

Transcatheter aortic valve implantation (TAVI) has been proven to be the preferred procedure for patients with symptomatic aortic stenosis (AS) who do not qualify for surgery [1-2]. TAVI has been recently showed to present similar or even inferior all-cause mortality rates compared to surgery [3], thus representing a valid alternative also in the elderly [4]. Acute kidney injury (AKI) is one of the strongest predictors of mortality after TAVI and has been associated with worsened short- and long-term cardiovascular (CV) outcomes.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.